New protein deposition tracers in the pipeline

Abstract Traditional nuclear medicine ligands were designed to target cellular receptors or transporters with a binding pocket and a defined structure–activity relationship. More recently, tracers have been developed to target pathological protein aggregations, which have less well-defined structure...

Full description

Bibliographic Details
Main Authors: Aleksandar Jovalekic, Norman Koglin, Andre Mueller, Andrew W. Stephens
Format: Article
Language:English
Published: SpringerOpen 2016-06-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
PET
Tau
Online Access:http://link.springer.com/article/10.1186/s41181-016-0015-3